IO Biotech's market cap is currently ―. The company's EPS TTM is $-2.156; its P/E ratio is -0.68; IO Biotech is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -25.83M	$ -22.12M	$ -20.65M	$ -16.64M	$ -19.86M
EBITDA	$ -25.63M	$ -21.92M	$ -20.46M	$ -16.46M	$ -19.68M
Net Income Common Stockholders	$ -26.18M	$ -21.68M	$ -21.18M	$ -17.04M	$ -20.09M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 143.19M	$ 165.50M	$ 110.09M	$ 128.53M	$ 142.59M
Total Assets	$ 150.72M	$ 172.55M	$ 117.56M	$ 136.00M	$ 151.81M
Total Debt	$ 2.49M	$ 2.60M	$ 2.77M	$ 2.83M	$ 2.79M
Net Debt	$ -140.70M	$ -162.90M	$ -107.32M	$ -125.70M	$ -139.80M
Total Liabilities	$ 17.56M	$ 14.96M	$ 13.04M	$ 12.63M	$ 12.95M
Stockholders Equity	$ 133.16M	$ 157.59M	$ 104.52M	$ 124.22M	$ 138.85M
Cash Flow	-
Free Cash Flow	$ -22.91M	$ -16.01M	$ -18.30M	$ -14.84M	$ -12.53M
Operating Cash Flow	$ -22.80M	$ -15.99M	$ -18.26M	$ -14.69M	$ -12.53M
Investing Cash Flow	$ -112.00K	$ -24.00K	$ -39.00K	$ -148.00K	$ -349.00K
Financing Cash Flow	$ -10.00K	$ 71.87M	-	-	-

Currency in USD

IO Biotech Earnings and Revenue History

Income Statement >

IO Biotech Debt to Assets

Balance Sheet >

IO Biotech Cash Flow

Cash Flow >

IO Biotech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing